SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001346302-20-000003
Filing Date
2020-03-11
Accepted
2020-03-11 06:09:29
Documents
3
Period of Report
2020-03-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K q42019earningsrelease8-k.htm 8-K 40120
2 EXHIBIT 99.1 exh991q42019earningsrelease.htm EX-99.1 131089
3 xerislpharmrgba12.jpg GRAPHIC 74582
  Complete submission text file 0001346302-20-000003.txt   275006
Mailing Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601
Business Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601 844-445-5704
XERIS PHARMACEUTICALS INC (Filer) CIK: 0001346302 (see all company filings)

IRS No.: 203352427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38536 | Film No.: 20703840
SIC: 2834 Pharmaceutical Preparations